/GTBIF
GTBIF Stock - Green Thumb Industries Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$8.40-4.22%
$0.37 (-4.22%) • Jan 13
85
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.93
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.84
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+102.4%upside
Target: $17.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GTBIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$8.32 – $8.48
TARGET (TP)$17.00
STOP LOSS$7.73
RISK/REWARD1:12.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.90
52W High$10.43
52W Low$4.63
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.05B | $1.02B | $893.56M | $556.57M |
| Gross Profit | $601.11M | $526.50M | $503.96M | $491.93M | $304.17M |
| Gross Margin | 52.9% | 49.9% | 49.5% | 55.1% | 54.7% |
| Operating Income | $224.43M | $184.63M | $121.06M | $124.37M | $106.11M |
| Net Income | $73.08M | $36.27M | $11.98M | $75.44M | $14.99M |
| Net Margin | 6.4% | 3.4% | 1.2% | 8.4% | 2.7% |
| EPS | $0.31 | $0.15 | $0.05 | $0.33 | $0.07 |
Company Overview
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GTBIFBeat Rate
44%
Last 18 quarters
Avg Surprise
+13.6%
EPS vs Estimate
Beats / Misses
8/9
1 met exactly
Latest EPS
$0.04
Q4 2025
EPS Surprise History
Q1 24
-76.0%
$0.01vs$0.04
Q2 24
+160.0%
$0.13vs$0.05
Q3 24
+80.0%
$0.09vs$0.05
Q4 24
-33.3%
$0.04vs$0.06
Q1 25
-33.3%
$0.04vs$0.06
Q2 25
-20.0%
$0.04vs$0.05
Q3 25
-125.0%
$-0.01vs$0.04
Q4 25
+33.3%
$0.04vs$0.03
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $0.01 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.03 | $0.04 | +33.3% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $0.04 | $-0.01 | -125.0% | ✗ MISS |
Q2 2025 | May 7, 2025 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Q3 2024 | Aug 5, 2024 | $0.05 | $0.09 | +80.0% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $0.05 | $0.13 | +160.0% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.04 | $0.01 | -76.0% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $0.04 | $0.05 | +19.3% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $0.05 | $0.05 | 0.0% | = MET |
Q2 2023 | May 3, 2023 | $0.04 | $0.04 | -9.9% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $0.07 | $0.05 | -28.6% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Q3 2022 | Aug 3, 2022 | $0.04 | $0.10 | +181.2% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $0.06 | $0.12 | +100.0% | ✓ BEAT |
Q1 2022 | Mar 1, 2022 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.10 | $0.08 | -20.0% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about GTBIF
What is GTBIF's current stock price?
Green Thumb Industries Inc. (GTBIF) is currently trading at $8.40 per share. The stock has moved -4.22% today.
What is the analyst price target for GTBIF?
The average analyst price target for GTBIF is $17.00, based on 1 analyst.
What sector is Green Thumb Industries Inc. in?
Green Thumb Industries Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is GTBIF's market cap?
Green Thumb Industries Inc. has a market capitalization of $1.95 billion, making it a small-cap company.
Does GTBIF pay dividends?
No, Green Thumb Industries Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARSUF
Fagron N.V.
$25.20
Mkt Cap: $1.8B
CHIZF
China Traditional Chinese Medicine Holdings Co. Limited
$0.27
Mkt Cap: $1.4B
GENSF
Genus plc
$35.00
Mkt Cap: $2.3B
GRRMF
Gerresheimer AG
$51.41
Mkt Cap: $1.8B
KSPHF
Kissei Pharmaceutical Co., Ltd.
$30.28
Mkt Cap: $1.3B
NPNKF
Nippon Shinyaku Co., Ltd.
$38.01
Mkt Cap: $2.6B
NPPNY
Nippon Shinyaku Co., Ltd.
$9.00
Mkt Cap: $2.4B
PHMMF
Pharma Mar, S.A.
$93.00
Mkt Cap: $1.6B
SWGHF
Sawai Group Holdings Co., Ltd.
$11.52
Mkt Cap: $1.3B
TCNNF
Trulieve Cannabis Corp.
$8.73
Mkt Cap: $1.7B
Explore stocks similar to GTBIF for comparison